NOMO1 and colorectal carcinoma: When we extended the analysis, we confirmed the important proportion or EOCRC cases showing NOMO1 loss, and preliminary findings also indicate that this loss is specific of CRC and, more significantly, that it appears to be an important clinical marker of MSS EOCRC as we observed the deletion in more than 90% of the cases.